НовостиBenzingaCitigroup Maintains Buy on Zenas BioPharma, Raises Price Target to $48 Citigroup Maintains Buy on Zenas BioPharma, Raises Price Target to $48 Benzinga 2026.09.30 20:35 (GMT+0) Открыть на Benzinga Другие новости